Lipidomics of Obesity, Type 2 Diabetes and Cardiovascular Disease

肥胖、2 型糖尿病和心血管疾病的脂质组学

• 批准号: nhmrc : GNT1042095
• 负责人: Prof Peter Meikle
• 金额: $ 72.78万
• 依托单位国家: 澳大利亚
• 项目类别: Research Fellowships
• 财政年份: 2013
• 资助国家: 澳大利亚
• 起止时间: 2013-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/lipidomics-obesity-type-cardiovascular-disease/1344396
• 关键词: Lipidomics; Obesity; Type; Diabetes; Cardiovascular

Obesity, type 2 diabetes and cardiovascular disease are major health problems in Australia and result in many tens of thousands of deaths each year. Changes in our metabolism lead to an imbalance in lipids (fats) circulating in our blood (dyslipidemia) which contributes to the disease process. This project will characterise these changes in circulating lipids to develop new tests to identify those at greatest risk of disease so that early treatment can be provided.

肥胖、2型糖尿病和心血管疾病是澳大利亚的主要健康问题，每年导致数万人死亡。我们新陈代谢的变化导致血液中循环的脂类(脂肪)失衡(血脂异常)，从而导致疾病进程。该项目将描述循环血脂的这些变化，以开发新的测试来识别那些疾病风险最高的人，以便能够提供早期治疗。